Caley Castelein insider trades: Tourmaline Bio (TRML) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Caley reports to the SEC
and 1 more company
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 27, 2023 | TRML | ↑ Buy | 20,000 | $14.03 | $281K | Direct | Oct 27, 2023 (0d) |
| Jul 19, 2023 | VRAY | ↓ Sell | 1,545,600 | $0.07 | $110K | Indirect | Jul 21, 2023 (2d) |
| Jul 19, 2023 | VRAY | ↓ Sell | 799,430 | $0.07 | $56K | Direct | Jul 21, 2023 (2d) |
| May 11, 2022 | VRAY | ↑ Buy | 1,415,000 | $2.54 | $3.6M | Indirect | May 12, 2022 (1d) |
| Aug 26, 2021 | AADI | ↑ Buy | 259,998 | $13.08 | $3.4M | Indirect | Aug 30, 2021 (4d) |
| Mar 15, 2017 | NONE | ↑ Buy | 400,000 | $5.00 | $2.0M | Indirect | Mar 17, 2017 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Caley Castelein's insider trades
Caley Castelein is an insider at Tourmaline Bio (TRML). Since Mar 15, 2017, Caley has reported 4 open-market purchases worth $9.3M and 2 sales worth $165K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (34 filings), other transactions (3 filings), shares returned to the company (2 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TRML insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.